Peter H. Crackett - Concepedia

Author

Peter H. Crackett

Corcept Therapeutics (United States)

Also Known As

Crackett, P., P. Crackett, P. H. CRACKETT, Peter Crackett, Peter H. Crackett

Publications

546

Citations

H-Index

Concepts

All Affiliations

Corcept Therapeutics (United States)Charles River Laboratories (United Kingdom)

About

Peter H. Crackett is an author at Corcept Therapeutics (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	380
2	Biochemistry	7	7	300
3	Natural Sciences	5	5	240
4	Engineering	2	2	91
5	Biomolecular Engineering	2	2	148

Peter H. Crackett

Publications

486

Citations

H-Index

Page 1

	Year	Citations
Studies toward the Large-Scale Synthesis of the HIV Proteinase Inhibitor Ro 31-8959 K. E. B. PARKES, D. J. BUSHNELL, Peter H. Crackett, The Journal of Organic Chemistry Altmetric Attention ScorePeptide ScienceAntiviral DrugSystems PharmacologyMedicinal Chemistry	1994	98
Identification of <i>C</i>-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2 Mark Zak, Christopher A. Hurley, Stuart I. Ward, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2013	61
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling Mark Zak, Emily J. Hanan, Patrick J. Lupardus, Bioorganic & Medicinal Chemistry Letters Effective Cell-based BlockadeSignaling PathwayNovel TherapyMedicineReceptor Tyrosine Kinase	2019	52
Asymmetric synthesis via acetal templates. 9. Further studies of the allylation reaction. Preparation of (−)-dihydromyoporone William S. Johnson, Peter H. Crackett, John D. Elliott, Tetrahedron Letters Cross-coupling ReactionEngineeringAsymmetric SynthesisOrganic ChemistryAcetal Templates	1984	50
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity Robin D. Clark, Nicholas C. Ray, Karen Williams, Bioorganic & Medicinal Chemistry Letters Selective Glucocorticoid ReceptorBiochemistryFunctional SelectivityMedicinePharmacological Agent	2008	49
Complexes of imidazoline (1,3H)-2-thione with Co(II) and Zn(II) salts Eric S. Raper, Peter H. Crackett Inorganica Chimica Acta Inorganic ChemistryEngineeringCoordination ComplexOrganic ChemistryMolecular Complex	1981	41
Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase Sharon Jackson, Sukhveen Sahni, Lan Lee, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryReactive Nitrogen SpecieNatural Sciences	2005	33
Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors Steve Price, Walter Bordogna, Richard J. Bull, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic ChemistryBiochemistryPotent Histone DeacetylaseMedicine	2006	30
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators Nicholas C. Ray, Robin D. Clark, David E. Clark, Bioorganic & Medicinal Chemistry Letters Functional SelectivityMedicinePhysiologyReceptor (Biochemistry)Pharmacotherapy	2007	28
Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1 Lewis Gazzard, Karen Williams, Huifen Chen, Journal of Medicinal Chemistry Ache ActivityDrug TargetPharmacotherapyChemical BiologyPharmaceutical Chemistry	2015	18

Page 1